'Qurr' line of revolutionary muscle-health and muscle-building products in newly-enhanced form set for March rollout
01 mars 2017 15h26 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Mar 1, 2017) - MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), today announced the upcoming launch of Qurr, its Fortetropin®-powered...
MYOS RENS Technology Inc. Adopts Shareholder Rights Plan
14 févr. 2017 18h00 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Feb 14, 2017) - MYOS RENS Technology Inc. (the "Company") (NASDAQ: MYOS) today announced that its Board of Directors ("Board") has adopted a shareholder rights plan...
MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering
03 févr. 2017 14h54 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Feb 3, 2017) - MYOS RENS Technology Inc. (the "Company") (NASDAQ: MYOS) today announced that an institutional investor has agreed to purchase approximately $2.125...
Dr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness'
30 janv. 2017 08h00 HE
|
Myos Rens Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Jan 30, 2017) - According to Dr. Robert Hariri, U.S. Chairman of MYOS RENS Technology Inc. (NASDAQ: MYOS), "the muscle company™," speaking recently on the...
MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript
29 sept. 2016 08h00 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Sep 29, 2016) - MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) announced today the publication of the peer-reviewed study of the human clinical...
MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer
07 sept. 2016 12h32 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Sep 7, 2016) - MYOS RENS Technology Inc. ("MYOS RENS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused...
MYOS Reports Positive Results From Fortetropin(R) Clinical Study
22 avr. 2016 15h00 HE
|
MYOS RENS Technology Inc.
CEDAR KNOLLS, NJ--(Marketwired - Apr 22, 2016) - MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the...
MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc.
22 mars 2016 07h33 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 22, 2016) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman
08 mars 2016 16h17 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 8, 2016) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces the Initial Closing of a Strategic Investment by RENS Technology Inc.
04 mars 2016 08h30 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 4, 2016) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...